% | $
Quotes you view appear here for quick access.

Provectus Biopharmaceuticals, Inc. Message Board

  • spaghetti_eddie spaghetti_eddie May 23, 2014 2:44 PM Flag

    Please lift the trading halt...

    Ok. The news is out. BTD not approved. now lift the trading halt. I want some cheap shares before people think this through.

    PVCT received notification from the United States Food and Drug Administration that the data upon which the Company based its request for designation of PV-10 as a Breakthrough Therapy for the treatment of patients with locally advanced cutaneous melanoma was insufficient to demonstrate substantial improvement over existing therapies. As a result, the FDA has declined to designate PV-10 as a Breakthrough Therapy at this time. Further data may cause the Agency to revisit this decision at a later date. PV-10 is the Company’s novel investigational drug for solid tumors

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.361+0.011(+3.11%)May 27 4:01 PMEDT